Blackstone Life Sciences announces $455 million collaboration with Boston Scientific

BX•2026-11-02

Blackstone Life Sciences announced a $455 million collaboration to co-fund development of Boston Scientific’s Vitalyst heart pump for patients with cardiogenic shock.

1. Development collaboration

Blackstone Life Sciences announced a $455 million collaboration with Boston Scientific to co-fund development of the Vitalyst heart pump for patients with cardiogenic shock.

Blackstone Life Sciences announces $455 million collaboration with Boston Scientific

1. Development collaboration

Related News

V2X files for mixed shelf; size not disclosed

Crescent Energy announces confidential IPO filing for royalty subsidiary

Astec Industries files initial beneficial ownership statement for director William E. Waltz Jr.

Pershing Square expects tax rate to normalize in low 20s% range and annual EPS growth of about 20%

TOP Ships announces $5 million private placement of convertible notes and warrants